» Articles » PMID: 35215316

PfMDR1 Transport Rates Assessed in Intact Isolated Digestive Vacuoles Reflect Functional Drug Resistance Relationship with Mutations

Overview
Publisher MDPI
Specialty Chemistry
Date 2022 Feb 26
PMID 35215316
Authors
Affiliations
Soon will be listed here.
Abstract

Drug resistance often emerges from mutations in solute transporters. Single amino acid exchanges may alter functionality of transporters with 'de novo' ability to transport drugs away from their site of action. The PfMDR1 transporter (or P-glycoprotein 1) is located in the membrane of the digestive vacuole (DV), functions as an ATP-dependent pump, and transports substrates into the DV. In this study, four strains of , carrying various gene mutations, were analysed for their transport characteristics of Fluo-4 in isolated DVs of parasites. To obtain quantitative estimates for PfMDR1 DV surface expression, PfMDR1 protein amounts on each strain's DV membrane were evaluated by quantitative ELISA. Fluo-4, acting as a substrate for PfMDR1, was applied in DV uptake assays ('reverse Ca imaging'). Viable DVs were isolated from trophozoite stages with preserved PfMDR1 activity. This newly developed assay enabled us to measure the number of Fluo-4 molecules actively transported into isolated DVs per PfMDR1 molecule. The drug-resistant strain Dd2 presented the highest transport rates, followed by K1 and the drug-sensitive strain 3D7, compatible with their copy numbers. With this assay, an evaluation of the probability of resistance formation for newly developed drugs can be implemented in early stages of drug development.

Citing Articles

Stereospecific Resistance to N2-Acyl Tetrahydro-β-carboline Antimalarials Is Mediated by a PfMDR1 Mutation That Confers Collateral Drug Sensitivity.

Bremers E, Butler J, Do Amaral L, Merino E, Almolhim H, Zhou B ACS Infect Dis. 2025; 11(2):529-542.

PMID: 39808111 PMC: 11828674. DOI: 10.1021/acsinfecdis.4c01001.


Access to Artemisinin-Triazole Antimalarials Organo-Click Reaction: High / Activity against Multi-Drug-Resistant Malaria Parasites.

Herrmann L, Leidenberger M, Quadros H, Grau B, Hampel F, Friedrich O JACS Au. 2024; 4(3):951-957.

PMID: 38559731 PMC: 10976565. DOI: 10.1021/jacsau.3c00716.


Critical interdependencies between Plasmodium nutrient flux and drugs.

Henshall I, Spielmann T Trends Parasitol. 2023; 39(11):936-944.

PMID: 37716852 PMC: 10580322. DOI: 10.1016/j.pt.2023.08.008.


Antiplasmodial Cyclodecapeptides from Tyrothricin Share a Target with Chloroquine.

Leussa A, Rautenbach M Antibiotics (Basel). 2022; 11(6).

PMID: 35740207 PMC: 9219824. DOI: 10.3390/antibiotics11060801.

References
1.
Veiga M, Dhingra S, Henrich P, Straimer J, Gnadig N, Uhlemann A . Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies. Nat Commun. 2016; 7:11553. PMC: 4873939. DOI: 10.1038/ncomms11553. View

2.
Nzila A, Mwai L . In vitro selection of Plasmodium falciparum drug-resistant parasite lines. J Antimicrob Chemother. 2009; 65(3):390-8. PMC: 2818104. DOI: 10.1093/jac/dkp449. View

3.
Chugh M, Scheurer C, Sax S, Bilsland E, van Schalkwyk D, Wicht K . Identification and deconvolution of cross-resistance signals from antimalarial compounds using multidrug-resistant Plasmodium falciparum strains. Antimicrob Agents Chemother. 2014; 59(2):1110-8. PMC: 4335906. DOI: 10.1128/AAC.03265-14. View

4.
Ding X, Ubben D, Wells T . A framework for assessing the risk of resistance for anti-malarials in development. Malar J. 2012; 11:292. PMC: 3478971. DOI: 10.1186/1475-2875-11-292. View

5.
Cowman A, KARCZ S, Galatis D, Culvenor J . A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole. J Cell Biol. 1991; 113(5):1033-42. PMC: 2289011. DOI: 10.1083/jcb.113.5.1033. View